FeesSafety
Pluang+

Law firm investigates VenHub Global over potential securities fraud after big losses and liquidity issues.

Market News
06 Nov 2026, 20:28 WIB
GlobeNewsWire
View Source
Bearish
Law firm investigates VenHub Global over potential securities fraud after big losses and liquidity issues.

Johnson Fistel, PLLP is investigating VenHub Global, Inc. following the company's 2025 annual report revealing $864,450 in revenue but a net loss of about $62.4 million. VenHub also reported significant financial distress, including a $13.9 million liability, a $10.3 million stockholders' deficit, and doubts about its ability to continue operating without new capital. The law firm is examining whether VenHub made false or misleading statements or failed to disclose important information to investors. Investors who suffered losses or hold VenHub stock are encouraged to contact Johnson Fistel for potential recovery options under federal securities laws.

VenHub Global, Inc. is under investigation following its 2025 financial report showing a net loss of about $62.4 million and significant liabilities. For readers following the Financials sector, here is Pluang's market snapshot as of Nov 07, 2026 00:11 WIB: out of 142 priced US Financials stocks, 69 rose and 72 fell. Notable movers include RIOT at USD 16.68 with a 13.01% increase and 80% buy order activity, AVAT at USD 0.75 down 7.15% with 85% sell orders, and WULF at USD 10.70 up 6.15% with 76% sell orders.

More News

Ipsen reports October 2026 share capital and voting rights details as required by French regulations.

Ipsen reports October 2026 share capital and voting rights details as required by French regulations.

Ipsen has disclosed its monthly update on the total number of shares and voting rights as of October 31, 2026. The company reported 83,814,526 shares composing the share capital, with a gross total of 132,059,377 voting rights and a net total of 130,...

Company Fundamentals
Neutral
1 hour ago
Ipsen Pharma reports total shares and voting rights as of October 2026, confirming capital structure details.

Ipsen Pharma reports total shares and voting rights as of October 2026, confirming capital structure details.

Ipsen Pharma has disclosed the total number of shares and voting rights composing its capital as of October 31, 2026. The company reported 83,814,526 shares and a gross total of 132,059,377 voting rights, with a net total of 130,677,690 after excludi...

Company Fundamentals
Neutral
1 hour ago
Chery shifts to Globalization 3.0, focusing on local integration and sustainability worldwide

Chery shifts to Globalization 3.0, focusing on local integration and sustainability worldwide

At its 2026 International User Summit, Chery unveiled its Globalization 3.0 strategy, moving beyond export-driven growth to emphasize deep localization, sustainable development, and community engagement. The company is expanding local R&D, manufactur...

Market News
Bullish
1 hour ago
Sodexo reports October 2026 share capital and voting rights update.

Sodexo reports October 2026 share capital and voting rights update.

Sodexo disclosed its monthly update on share capital and voting rights as of October 31, 2026. The company has 147,454,887 shares with actual voting rights totaling 216,485,145, reflecting shares with single and double voting rights. This update is p...

Company Fundamentals
Neutral
1 hour ago
Sodexo reports total shares and voting rights as of October 31, 2026, with 147.5M shares outstanding.

Sodexo reports total shares and voting rights as of October 31, 2026, with 147.5M shares outstanding.

Sodexo announced its monthly update on the total number of shares and voting rights as of October 31, 2026. The company has 147,454,887 shares composing its capital, with 216,485,145 exercisable voting rights and 218,335,896 theoretical voting rights...

Company Fundamentals
Neutral
1 hour ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App